PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
23660265-7	2013	Gene analysis confirmed heterozygous mis-sense mutation at codon 918 in exon 16 of RET proto-oncogene in which thymine was replaced by cytosine (ATG ACG).	Thymine	111-118	ret proto-oncogene	Homo sapiens	83-86	
21253810-1	2011	The most important mutation associated with Multiple Endocrine Neoplasia type 2B (MEN 2B) is the change of thymine to cytosine in codon 918 of exon 16 in the RET oncogene (ATG   ACG).	Thymine	107-114	ret proto-oncogene	Homo sapiens	44-80	
21253810-1	2011	The most important mutation associated with Multiple Endocrine Neoplasia type 2B (MEN 2B) is the change of thymine to cytosine in codon 918 of exon 16 in the RET oncogene (ATG   ACG).	Thymine	107-114	ret proto-oncogene	Homo sapiens	82-88	
21253810-1	2011	The most important mutation associated with Multiple Endocrine Neoplasia type 2B (MEN 2B) is the change of thymine to cytosine in codon 918 of exon 16 in the RET oncogene (ATG   ACG).	Thymine	107-114	ret proto-oncogene	Homo sapiens	158-161	
9012117-3	1996	The most frequent hereditary mutation found in MEN 2A and FMTC groups is substitution of thymine for cytosine in position 2095 of the transmembranous domain of the Ret-tyrosine kinase gene.	Thymine	89-96	ret proto-oncogene	Homo sapiens	47-53	
9012117-3	1996	The most frequent hereditary mutation found in MEN 2A and FMTC groups is substitution of thymine for cytosine in position 2095 of the transmembranous domain of the Ret-tyrosine kinase gene.	Thymine	89-96	ret proto-oncogene	Homo sapiens	164-167